Optimizing targeted therapy and developing novel outcome measures for patients with advanced prostate cancer at Memorial Sloan-Kettering Cancer Center

This publication has 51 references indexed in Scilit:

• Histone deacetylases and cancer: causes and therapies
  Nature Reviews Cancer, 2001
• Positron emission tomography with ¹⁸fluorine‐labelled deoxyglucose: utility in localized and advanced prostate cancer
  BJU International, 1999
• COMPARISON OF HELICAL COMPUTERIZED TOMOGRAPHY, POSITRON EMISSION TOMOGRAPHY AND MONOCLONAL ANTIBODY SCANS FOR EVALUATION OF LYMPH NODE METASTASES IN PATIENTS WITH PROSTATE SPECIFIC ANTIGEN RELAPSE AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER
  Journal of Urology, 1999
• The hsp90-binding Antibiotic Geldanamycin Decreases Raf Levels and Epidermal Growth Factor Signaling without Disrupting Formation of Signaling Complexes or Reducing the Specific Enzymatic Activity of Raf Kinase
  Journal of Biological Chemistry, 1997
• Clinical Trials in Relapsed Prostate Cancer: Defining the Target
  JNCI Journal of the National Cancer Institute, 1996
• How Much Can We Rely on the Level of Prostate-Specific Antigen as an End Point for Evaluation of Clinical Trials? A Word of Caution!
  JNCI Journal of the National Cancer Institute, 1996
• Metabolic Imaging of Untreated Prostate Cancer by Positron Emission Tomography with sup 18 Fluorine-Labeled Deoxyglucose
  Journal of Urology, 1996
• Herbimycin A Induces the 20 S Proteasome- and Ubiquitin-dependent Degradation of Receptor Tyrosine Kinases
  Journal of Biological Chemistry, 1995
• Synthesis of 11.beta.-[18F]Fluoro-5.alpha.-dihydrotestosterone and 11.beta.-[18F]Fluoro-19-nor-5.alpha.-dihydrotestosterone: Preparation via Halofluorination-Reduction, Receptor Binding, and Tissue Distribution
  Journal of Medicinal Chemistry, 1995
• Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow.
  Journal of Clinical Investigation, 1989